nodes	percent_of_prediction	percent_of_DWPC	metapath
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—HDAC1—ocular cancer	0.0434	0.0434	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—HDAC1—ocular cancer	0.0408	0.0408	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—E2F4—ocular cancer	0.0293	0.0293	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—RBL1—ocular cancer	0.0287	0.0287	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.0275	0.0275	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—RBL2—ocular cancer	0.0263	0.0263	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.0259	0.0259	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—HDAC1—ocular cancer	0.0213	0.0213	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—EP300—ocular cancer	0.0173	0.0173	CbGpPWpGaD
Bexarotene—RXRG—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ocular cancer	0.0169	0.0169	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—EP300—ocular cancer	0.0163	0.0163	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—CDK4—ocular cancer	0.016	0.016	CbGpPWpGaD
Bexarotene—RXRB—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ocular cancer	0.0159	0.0159	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—CCND3—ocular cancer	0.0156	0.0156	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—E2F4—ocular cancer	0.0143	0.0143	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—RBL1—ocular cancer	0.0141	0.0141	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.0137	0.0137	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—HDAC1—ocular cancer	0.0135	0.0135	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—RBL2—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.0129	0.0129	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—E2F1—ocular cancer	0.0111	0.0111	CbGpPWpGaD
Bexarotene—RXRG—Regulation of Androgen receptor activity—EP300—ocular cancer	0.011	0.011	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—E2F5—ocular cancer	0.0109	0.0109	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—E2F4—ocular cancer	0.0107	0.0107	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—E2F4—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—RBL1—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Bexarotene—RXRG—Retinoic acid receptors-mediated signaling—AKT1—ocular cancer	0.0105	0.0105	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—RBL1—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—CCND1—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Bexarotene—RXRB—Regulation of Androgen receptor activity—EP300—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—E2F5—ocular cancer	0.0103	0.0103	CbGpPWpGaD
Bexarotene—RXRA—REV-ERBA represses gene expression—EP300—ocular cancer	0.0101	0.0101	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—E2F4—ocular cancer	0.01	0.01	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—RBL1—ocular cancer	0.00985	0.00985	CbGpPWpGaD
Bexarotene—RXRB—Retinoic acid receptors-mediated signaling—AKT1—ocular cancer	0.00983	0.00983	CbGpPWpGaD
Bexarotene—RXRA—RORA activates circadian gene expression—EP300—ocular cancer	0.00981	0.00981	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—SF3B1—ocular cancer	0.00896	0.00896	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—HRAS—ocular cancer	0.00856	0.00856	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—EP300—ocular cancer	0.00848	0.00848	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—TFDP1—ocular cancer	0.00844	0.00844	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—SF3B1—ocular cancer	0.00842	0.00842	CbGpPWpGaD
Bexarotene—RXRA—PPAR Alpha Pathway—MYC—ocular cancer	0.00829	0.00829	CbGpPWpGaD
Bexarotene—RXRA—RXR and RAR heterodimerization with other nuclear receptor—TGFB1—ocular cancer	0.00827	0.00827	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—HRAS—ocular cancer	0.00805	0.00805	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—TFDP1—ocular cancer	0.00794	0.00794	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—RB1—ocular cancer	0.00783	0.00783	CbGpPWpGaD
Bexarotene—RXRG—a6b1 and a6b4 Integrin signaling—AKT1—ocular cancer	0.00756	0.00756	CbGpPWpGaD
Bexarotene—RXRA—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—ocular cancer	0.00717	0.00717	CbGpPWpGaD
Bexarotene—RXRB—a6b1 and a6b4 Integrin signaling—AKT1—ocular cancer	0.00711	0.00711	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—CDK4—ocular cancer	0.00671	0.00671	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—MDM2—ocular cancer	0.00671	0.00671	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MAML2—ocular cancer	0.00671	0.00671	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—EIF1AX—ocular cancer	0.00631	0.00631	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MAML2—ocular cancer	0.00631	0.00631	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—EIF1AX—ocular cancer	0.00593	0.00593	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—CDKN1A—ocular cancer	0.00563	0.00563	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—E2F1—ocular cancer	0.00542	0.00542	CbGpPWpGaD
Bexarotene—RXRA—Regulation of Androgen receptor activity—EP300—ocular cancer	0.00538	0.00538	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—E2F5—ocular cancer	0.00534	0.00534	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—E2F5—ocular cancer	0.00525	0.00525	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—E2F4—ocular cancer	0.00523	0.00523	CbGpPWpGaD
Bexarotene—RXRA—Circadian Clock—EP300—ocular cancer	0.00522	0.00522	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—E2F4—ocular cancer	0.00514	0.00514	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—RBL1—ocular cancer	0.00513	0.00513	CbGpPWpGaD
Bexarotene—RXRA—Retinoic acid receptors-mediated signaling—AKT1—ocular cancer	0.00513	0.00513	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RBL1—ocular cancer	0.00504	0.00504	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RPL39—ocular cancer	0.00504	0.00504	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—E2F5—ocular cancer	0.00494	0.00494	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—HDAC1—ocular cancer	0.00491	0.00491	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—E2F4—ocular cancer	0.00484	0.00484	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RPL39—ocular cancer	0.00474	0.00474	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RBL1—ocular cancer	0.00474	0.00474	CbGpPWpGaD
Bexarotene—RXRG—Adipogenesis—TGFB1—ocular cancer	0.00466	0.00466	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—HDAC1—ocular cancer	0.00461	0.00461	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—CDKN2B—ocular cancer	0.0044	0.0044	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—SF3B1—ocular cancer	0.00439	0.00439	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—RBBP4—ocular cancer	0.00437	0.00437	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00434	0.00434	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—HRAS—ocular cancer	0.0042	0.0042	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—TFDP1—ocular cancer	0.00414	0.00414	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00413	0.00413	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—RBBP4—ocular cancer	0.00411	0.00411	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—TFDP1—ocular cancer	0.00407	0.00407	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—EP300—ocular cancer	0.00399	0.00399	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.00398	0.00398	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—RB1—ocular cancer	0.00384	0.00384	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—TFDP1—ocular cancer	0.00382	0.00382	CbGpPWpGaD
Bexarotene—RXRA—a6b1 and a6b4 Integrin signaling—AKT1—ocular cancer	0.00371	0.00371	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CCND3—ocular cancer	0.00353	0.00353	CbGpPWpGaD
Bexarotene—RXRA—Transcriptional regulation of white adipocyte differentiation—TGFB1—ocular cancer	0.00347	0.00347	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.00343	0.00343	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—PSPH—ocular cancer	0.00341	0.00341	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MAML2—ocular cancer	0.00329	0.00329	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.00325	0.00325	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MAML2—ocular cancer	0.00323	0.00323	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—EIF1AX—ocular cancer	0.00309	0.00309	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MAML2—ocular cancer	0.00304	0.00304	CbGpPWpGaD
Bexarotene—RXRA—PPARA activates gene expression—EP300—ocular cancer	0.003	0.003	CbGpPWpGaD
Bexarotene—RXRA—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—ocular cancer	0.00294	0.00294	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—CDKN1A—ocular cancer	0.00276	0.00276	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—E2F5—ocular cancer	0.00257	0.00257	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—E2F4—ocular cancer	0.00252	0.00252	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RPL39—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RBL1—ocular cancer	0.00247	0.00247	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00241	0.00241	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—HDAC1—ocular cancer	0.0024	0.0024	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—HDAC1—ocular cancer	0.00236	0.00236	CbGpPWpGaD
Bexarotene—RXRA—Adipogenesis—TGFB1—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—HDAC1—ocular cancer	0.00222	0.00222	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.0022	0.0022	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—CDKN2B—ocular cancer	0.00215	0.00215	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—RBBP4—ocular cancer	0.00214	0.00214	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—CDKN2B—ocular cancer	0.00212	0.00212	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.0021	0.0021	CbGpPWpGaD
Bexarotene—RXRA—NRF2 pathway—TGFB1—ocular cancer	0.00208	0.00208	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.00203	0.00203	CbGpPWpGaD
Bexarotene—RXRA—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—ocular cancer	0.00202	0.00202	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—TFDP1—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—CDKN2B—ocular cancer	0.00199	0.00199	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.00193	0.00193	CbGpPWpGaD
Bexarotene—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Bexarotene—RXRG—Generic Transcription Pathway—MYC—ocular cancer	0.0017	0.0017	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.00168	0.00168	CbGpPWpGaD
Bexarotene—RXRB—Generic Transcription Pathway—MYC—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MAML2—ocular cancer	0.00158	0.00158	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—CDK4—ocular cancer	0.00152	0.00152	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.00138	0.00138	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—PSPH—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Bexarotene—RXRA—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00117	0.00117	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—HDAC1—ocular cancer	0.00116	0.00116	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNA11—ocular cancer	0.00107	0.00107	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—CDKN2B—ocular cancer	0.00104	0.00104	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—GNAQ—ocular cancer	0.000998	0.000998	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—EP300—ocular cancer	0.000902	0.000902	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—PSPH—ocular cancer	0.00084	0.00084	CbGpPWpGaD
Bexarotene—RXRA—Generic Transcription Pathway—MYC—ocular cancer	0.000835	0.000835	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—MYC—ocular cancer	0.00082	0.00082	CbGpPWpGaD
Bexarotene—RXRA—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000806	0.000806	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—TGFB1—ocular cancer	0.000784	0.000784	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—MYC—ocular cancer	0.000771	0.000771	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—HRAS—ocular cancer	0.000617	0.000617	CbGpPWpGaD
Bexarotene—RXRG—Gene Expression—AKT1—ocular cancer	0.000569	0.000569	CbGpPWpGaD
Bexarotene—RXRA—Developmental Biology—AKT1—ocular cancer	0.000545	0.000545	CbGpPWpGaD
Bexarotene—RXRB—Gene Expression—AKT1—ocular cancer	0.000535	0.000535	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—MYC—ocular cancer	0.000402	0.000402	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNA11—ocular cancer	0.000401	0.000401	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—GNAQ—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—EP300—ocular cancer	0.000359	0.000359	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Bexarotene—RXRA—Gene Expression—AKT1—ocular cancer	0.000279	0.000279	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNA11—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000246	0.000246	CbGpPWpGaD
Bexarotene—RXRA—Metabolism—AKT1—ocular cancer	0.000217	0.000217	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—EP300—ocular cancer	0.000134	0.000134	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—EP300—ocular cancer	8.83e-05	8.83e-05	CbGpPWpGaD
Bexarotene—CYP2C9—Metabolism—AKT1—ocular cancer	8.09e-05	8.09e-05	CbGpPWpGaD
Bexarotene—CYP3A4—Metabolism—AKT1—ocular cancer	5.34e-05	5.34e-05	CbGpPWpGaD
